Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2025Current Protocols

Synthesis and Application of BRD4‐Targeting ByeTACs (Bypassing E‐Ligase Targeting Chimeras)

View Full Paper
Ask AI
Bookmark
Share

Authors

CLCody A. LoyTHTimothy HarrisDTDarci J. Trader

Discussion

Loading...

Member takes

Overview

Targeted protein degradation bypasses E3 ligases to enhance drug discovery, highlighting ByeTACs' efficacy.

Key Points

  • ByeTACs effectively degrade BRD4 without needing E3 ligases, improving upon traditional methods.
  • The system showed significant capability in recruiting proteins directly to the 26S proteasome for degradation.
  • Using bifunctional molecules, ByeTACs overcome common limitations associated with the ubiquitin-proteasome pathway.
  • This work may enable the development of novel therapeutics for various proteins that are hard to ubiquitinate.

Cite This Study

Loy et al. (2025) studied this question.

synapsesocial.com/papers/68c23595b210217d6477139chttps://doi.org/10.1002/cpz1.70196
View Full Paper
Ask AI
Bookmark
Share